Background: cholestasis is a prevalent health problem associated with liver oxidative stress, inflammation, and fibrosis. Quercetin has been shown to afford a beneficial effect in a variety of liver diseases. This study was designed to investigate the potential protective effect of quercetin on liver cholestasis and the possible underlying mechanisms in a rat model of bile duct ligation (BDL). Methods: This study was carried out on adult male rats which were randomly divided into: Sham-operated, BDL and BDL-quercetin treated (BDL-Q) groups. Quercetin was given by gavage in a dose of 50 mg/kg/day. Results: Bile duct ligation resulted in a significant increase in serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and liver levels of myeloperoxidase (MPO), tumor necrosis factor alpha (TNF-α),and transforming growth factor beta 1(TGF-β1), along with a significant decrease in serum levels of total proteins (TPs) and liver glutathione peroxidase(GPX) in BDL group versus sham-operated controls. Quercetin treatment significantly lowered serum levels of AST, ALT, ALP, and MPO, TNF-α, and TGF-β1 in liver tissues associated with a significant increase in serum TPs and liver GPX in BDL-Q group versus BDL rats. Histological studies revealed enhancement of inflammation and a significant increase in the percentage area of collagen deposition in BDL versus sham-operated group. These changes were attenuated in BDL-Q group compared to BDL rats. Conclusions: Quercetin alleviated cholestasis induced liver injury and improved liver function possibly via attenuating liver oxidative stress, inflammation and fibrosis.
INTRODUCTION
Chronic cholestasis is a prevalent health problem [1] produced by impairment of bile flow and/or secretion followed by accumulation of toxic bile acids in hepatocytes, evoking severe liver injury which may progress to cirrhosis and liver failure [2] . It is caused by various etiologies such as primary biliary cirrhosis, primary sclerosing cholangitis and progressive familial intrahepatic cholestasis [3] .
Recent studies emphasized the crucial role of oxidative stress as well as inflammation in the development and progression of liver injury during cholestasis [4] . Exposure of hepatocytes to high concentrations of potentially toxic bile acids initiates hepatocellular injury, followed by a leukocytic phase in which activated neutrophils infiltrate and attack the bile acid stressed hepatocytes through reactive oxygen species (ROS) formation [5] . Excessive production of ROS has been demonstrated to induce cellular damage [6] and promote inflammation by upregulating TNF-α signaling pathway, and IL-6 mRNA expression in chronic liver diseases [7] .
TGF-β, a potent profibrotic cytokine, was also activated by oxidative stress [8] and in a consequence stimulates the transformation of hepatic stellate cells into myofibroblasts which increase the extracellular matrix formation, promoting liver fibrosis [9] . During the past decades, the mechanisms of liver cholestasis have been investigated, but few therapeutic strategies are available to efficiently interrupt the progression of liver injury.
Quercetin (3, 3, 4 ,5,7-pentahydroxyflavone), a natural flavonoid compound found in vegetables and fruits, has a prominent antioxidant, and anti-inflammatory activities [10] . Quercetin was found to downregulate the serum levels of immunoinflammatory mediators, TNF-α, IL-6 and Creactive protein, protecting liver in atitanium dioxide nanoparticles induced liver injury rat model [11] . Additionally, quercetin affords antifibrotic effect by preventing TGF-β signaling pathways and fibroblast activation in carbon tetrachloride and thioacetamide induced hepatic toxicity in rats [6] . Therefore, it is highly possible that quercetin may be effective in prohibiting oxidative stress induced liver injury in chronic cholestasis. Thus, the present study was planned to investigate the possible protective effect and the related mechanisms of quercetin against cholestasis induced by bile duct ligation in rats, a well settled experimental model of cholestasis that initiates a complex cascade of pathological events similar to that of human [12] . 
Materials and Methods

Animals
Surgical procedure and Quercetintreatment
Common bile duct ligation was performed according to Haddadian et al [13] . Briefly, a midline abdominal incision was made and the peritoneal cavity was opened under complete sterile conditions. The common bile duct was exposed at its entry to the intestine and was double ligated with a 3/0 silk suture. The peritoneal cavity was rinsed with 0.9% NaCl solution, and the abdominal organs were placed to their positions and the incision was closed [13] .
Quercetin treatment started on the 4 th day of the operation, to minimize the exposure of rats to pain stress, and extended till the 28 th day of the operation. Quercetin (3,3',4',5,6-Pentahydroxyflavone, Sigma, St. Louis, Missouri, USA ) was dissolved in distilled water (D.W.) and
given by gavage in a dose of 50 mg/Kg / day [14] .
At the end of the experimental period the overnight fasted rats were weighed (BW),anesthetized, and blood samples were collected from abdominal aorta in plastic tubes.
Blood was allowed to coagulate at room temperature then centrifuged at 3000 rpm. for 15 min. and serum was collected and stored at - transforming growth factor beta (TGF-β1).
Biochemical analysis:
Using kits supplied by Biodiagnostic (Giza, Egypt), serum AST and ALT were determined according to the methods described by Reitman and Frankel [16] .Serum ALP, and TPs were measuredaccording to the methods reported by Belfield and Goldberg [17] ; and Gornal et al.
[18], respectively.
Measurement of MPOand GPX in liver tissue
MPOwas measured by using myeloperoxidase ELISA Kit (BioSource International, Inc., California, USA.).GPXwas measured according to the method described by Paglia and Valentine [19] , using kits supplied by Biodiagnostic (Giza, Egypt).
Measurement of TNF-α and TGF-β1 in liver tissue
TNF-α was determined using
RayBio® Rat TNF-alpha ELISA Kit ( RayBiotech, Inc., Norcross, Georgia, USA.) according to the manufacturer's instructions. TGF-β1 was determined by quantitative sandwich ELISA method according to Sporn et al. [20] , by using Rat TGF-β1 PicoKine ™ ELISA Kits(Pleasanton, USA.).
Histological examination:
Liver tissues were fixed in 10% formalin, 
Statistical analysis:
One-way analysis of variance (ANOVA) was used to determine the differences between groups. In the case of a significant F value (P ≤ 0.05), a least significant difference test was used to find significant intergroup differences. P values ≤0.05 were considered statistically significant.
SPSS windows version 20 (SPSS Inc., Chicago, IL, USA) was used in the analysis.
Results
Changes in hepatosomatic and splenosomatic indices:
Hepatosomatic and splenosomatic indices were significantly higher in BDL rats compared to 
Changes in serum levels of enzyme markers of liver injury and total proteins (TPs):
AST, ALT and ALP, were significantly elevated in BDL rats versus sham-operated group. All were significantly diminished in BDL-Q group versus BDL rats, achieving levels equivalent to those of the sham-operated group except for AST( Figure   1 ).
TPs were significantly decreased in BDL group compared to sham-operated group. Quercetin treatment significantly increased the TPs in BDL-Q group versus BDL rats, restoring their levels to match those of the sham-operated group ( Figure   1 ).
Changes in liver tissue levels of oxidative stress parameters:
A significant increase in MPO associated with a significant decrease in GPX were observed in BDL group versus sham-operated group. Quercetin treatment significantly decreased MPO and increased GPX in BDL-Q group compared to BDL rats ( Figure 2 ).
Changes in liver tissue levels of TNF-α, and
TGF-β1:
BDL rats presented significantly higher levels of TNF-α, and TGF-β1, compared to sham-operated group.
Quercetin treatment significantly diminished TNF-α and TGF-β1 in BDL-Q group versus BDL rats (Figure 2 ).
Histological and morphological changes
Hematoxylin and eosin stained liver sections
Sham-operated group showed normal architecture of classic hepatic lobules ( Fig. 3 A and B ). BDL group showed moderate periportal inflammation with areas of lobular necrosis (Figure 3 C, D and E). BDL-Q group showed mild periportal inflammation with no lobular inflammation or necrosis. (Fig.3 F and G) .
Masson's trichrome stained liver sections
Sham-operated group showed average collagen distribution around central veins and in portal tracts ( Fig. 4 A and B ). BDL group showed dense deposition of collagen fibers in the portal and periportal areas ( Fig.4 C and D) . In BDL-Q group, evident decrease in the amount of collagen fibers was identified ( Fig.4 E and F) . Changes in the percentage area of collagen fibers in the three study groups. a: significance of difference from SHAM group. b: significance of difference from BDL group.
Discussion
The main finding of the present study is that It is noteworthy that oxidative stress and its constant companion inflammation, findings recorded in BDL group in the present study, are principle contributors to liver fibrosis [34] . They have been implicated in activation of hepatic stellate cell (HSC) [35] , the principle cell-type that mediates hepatic collagen formation [36] .
Activation of HSCs was found to trigger their differentiation into myofibroblast-like cells that release TGF-β1 [23] .
Earlier, Derynck and Zhang [37] reported that TGF-β1 is a potent profibrotic cytokine that increases collagen production as well as tissue inhibitors of metalloproteinases, leading to decreased extracellular matrix degradation and increased extracellular matrix accumulation. 
